Business ❯ Pharmaceuticals ❯ Drug Development ❯ Weight Loss Drugs

Wegovy

Wegovy Wins FDA Nod for MASH as Novo Rolls Out $499 Cash Ozempic in U.S.

A fresh approval plus a $499 cash offer signals a bid to widen access, blunt copycats.

Lilly’s Oral GLP-1 Pill Underperforms Wegovy in Late-Stage Trial

Novo Nordisk Cuts 2025 Outlook and Names New CEO as Shares Plunge

Novo Nordisk Launches Wegovy Weight-Loss Drug in India